The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
In vitro Models of Neurodegenerative Diseases
Open accessAbstract
Neurodegenerative diseases are progressive degenerative conditions characterized by the functional deterioration and ultimate loss of neurons. These incurable and debilitating diseases affect millions of people worldwide, and therefore represent a major global health challenge with severe implications for individuals and society. Recently, several neuroprotective drugs have failed in human clinical trials despite promising pre-clinical data, suggesting that conventional cell cultures and animal models cannot precisely replicate human pathophysiology. To bridge the gap between animal and human studies, three-dimensional cell culture models have been developed from human or animal cells, allowing the effects of new therapies to be predicted more accurately by closely replicating some aspects of the brain environment, mimicking neuronal and glial cell interactions, and incorporating the effects of blood flow. In this review, we discuss the relative merits of different cerebral models, from traditional cell cultures to the latest high-throughput three-dimensional systems. We discuss their advantages and disadvantages as well as their potential to investigate the complex mechanisms of human neurodegenerative diseases. We focus on in vitro models of the most frequent age-related neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease and prion disease, and on multiple sclerosis, a chronic inflammatory neurodegenerative disease affecting young adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
An in vivo model of functional and vascularized human brain organoids
Mansour, A. A., Gonçalves, J. T., Bloyd, C. W., Li, H., Fernandes, S., Quang, D., Johnston, S., Parylak, S. L., Jin, X., & Gage, F. H. (2018) · Nature Biotechnology · doi:10.1038/nbt.4127 · Cited by 1,211
A three-dimensional human neural cell culture model of Alzheimer’s disease
Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., et al. (2014) · Nature · doi:10.1038/nature13800 · Cited by 1,195
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
Review Article: Genetics of Alzheimer Disease
Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Engineering of human brain organoids with a functional vascular-like system
Cakir, B., Xiang, Y., Tanaka, Y., Kural, M. H., Parent, M., Kang, Y.-J., Chapeton, K., Patterson, B., Yuan, Y., He, C.-S., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0586-5 · Cited by 942
Functional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
Self-citationT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865
Self-citationEncinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
Self-citationLRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, W., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.013 · Cited by 745
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741 · cited 1×
“Alzheimer’s disease Choi et al., 2014; Zollo et al., 2017 Kondo et al., 2013; Muratore et al., 2014; Sproul et al., 2014.”
BackgroundMissing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.
Ghasemi, N., Razavi, S., & Nikzad, E. (2016) · PubMed · doi:10.22074/cellj.2016.4867 · Cited by 685
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12191 · Cited by 651
The blood-brain barrier: Physiology and strategies for drug delivery
Pandit, R., Chen, L., & Götz, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.009 · Cited by 651
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
Park, J., Wetzel, I., Marriott, I., Dréau, D., D’Avanzo, C., Kim, D. Y., Tanzi, R. E., & Cho, H. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0175-4 · Cited by 644
Colonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627
Microglia innately develop within cerebral organoids
Ormel, P. R., Vieira de Sá, R., van Bodegraven, E. J., Karst, H., Harschnitz, O., Sneeboer, M. A. M., Johansen, L. E., van Dijk, R. E., Scheefhals, N., Berdenis van Berlekom, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06684-2 · Cited by 623
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 584
Raja, W. K., Mungenast, A. E., Lin, Y.-T., Ko, T., Abdurrob, F., Seo, J., & Tsai, L.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161969 · Cited by 569
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Generation of human vascularized brain organoids
Pham, M. T., Pollock, K. M., Rose, M. D., Cary, W. A., Stewart, H. R., Zhou, P., Nolta, J. A., & Waldau, B. (2018) · NeuroReport · doi:10.1097/wnr.0000000000001014 · Cited by 512
Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease
Nagele, R. G., Wegiel, J., Venkataraman, V., Imaki, H., Wang, K.-C., & Wegiel, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.007 · Cited by 504
Agholme, L., Lindström, T., Kågedal, K., Marcusson, J., & Hallbeck, M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091363 · Cited by 498
Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent
Fujimori, K., Ishikawa, M., Otomo, A., Atsuta, N., Nakamura, R., Akiyama, T., Hadano, S., Aoki, M., Saya, H., Sobue, G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0140-5 · Cited by 494
Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486
Hu, W., Qiu, B., Guan, W., Wang, Q., Wang, M., Li, W., Gao, L., Shen, L., Huang, Y., Xie, G., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.006 · Cited by 484
Strategies to advance translational research into brain barriers
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70326-5 · Cited by 474
Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C. S., Höing, S., Moritz, S., Parga, J. A., Wagner, L., Bruder, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059252 · Cited by 442
Living on the edge with too many mouths to feed: Why dopamine neurons die
Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 436
Ryan, S. D., Dolatabadi, N., Chan, S. F., Zhang, X., Akhtar, M. W., Parker, J., Soldner, F., Sunico, C. R., Nagar, S., Talantova, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.009 · Cited by 434
Modeling amyloid beta and tau pathology in human cerebral organoids
Gonzalez, C., Armijo, E., Bravo-Alegria, J., Becerra-Calixto, A., Mays, C. E., & Soto, C. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0229-8 · Cited by 430
Osaki, T., Uzel, S. G. M., & Kamm, R. D. (2018) · Science Advances · doi:10.1126/sciadv.aat5847 · Cited by 421
Animal Models of Alzheimer Disease
LaFerla, F. M., & Green, K. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006320 · Cited by 419
The hope and the hype of organoid research
Huch, M., Knoblich, J. A., Lutolf, M. P., & Martinez-Arias, A. (2017) · Development · doi:10.1242/dev.150201 · Cited by 409
Heemels, M.-T. (2016) · Nature · doi:10.1038/539179a · Cited by 407
Ahn, S. I., Sei, Y. J., Park, H.-J., Kim, J., Ryu, Y., Choi, J. J., Sung, H.-J., MacDonald, T. J., Levey, A. I., & Kim, Y. (2020) · Nature Communications · doi:10.1038/s41467-019-13896-7 · Cited by 402
Self‐organized developmental patterning and differentiation in cerebral organoids
Renner, M., Lancaster, M. A., Bian, S., Choi, H., Ku, T., Peer, A., Chung, K., & Knoblich, J. A. (2017) · The EMBO Journal · doi:10.15252/embj.201694700 · Cited by 389
Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions
Henderson, A. P. D., Barnett, M. H., Parratt, J. D. E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21800 · Cited by 387
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379
Stem Cell Models of Human Brain Development
Kelava, I., & Lancaster, M. A. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.05.022 · Cited by 378
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
Reitz, C. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/369808 · Cited by 376
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
An, M. C., Zhang, N., Scott, G., Montoro, D., Wittkop, T., Mooney, S., Melov, S., & Ellerby, L. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.026 · Cited by 376
Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport
Freundt, E. C., Maynard, N., Clancy, E. K., Roy, S., Bousset, L., Sourigues, Y., Covert, M., Melki, R., Kirkegaard, K., & Brahic, M. (2012) · Annals of Neurology · doi:10.1002/ana.23747 · Cited by 372
Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures
Marton, R. M., Miura, Y., Sloan, S. A., Li, Q., Revah, O., Levy, R. J., Huguenard, J. R., & Pașca, S. P. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0316-9 · Cited by 362
Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling
Mekhoubad, S., Bock, C., de Boer, A. S., Kiskinis, E., Meissner, A., & Eggan, K. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.014 · Cited by 360
CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes
Bechler, M. E., Byrne, L., & ffrench-Constant, C. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.056 · Cited by 359
Modeling Parkinson’s disease in midbrain-like organoids
Smits, L. M., Reinhardt, L., Reinhardt, P., Glatza, M., Monzel, A. S., Stanslowsky, N., Rosato-Siri, M. D., Zanon, A., Antony, P. M., Bellmann, J., et al. (2019) · npj Parkinson's Disease · doi:10.1038/s41531-019-0078-4 · Cited by 356
Induction of myelinating oligodendrocytes in human cortical spheroids
Madhavan, M., Nevin, Z. S., Shick, H. E., Garrison, E., Clarkson-Paredes, C., Karl, M., Clayton, B. L. L., Factor, D. C., Allan, K. C., Barbar, L., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0081-4 · Cited by 353
Multiple sclerosis: Pathology, diagnosis and treatments
Huang, W.-J., Chen, W.-W., & Zhang, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4410 · Cited by 351
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
Kim, H., Park, H. J., Choi, H., Chang, Y., Park, H., Shin, J., Kim, J., Lengner, C. J., Lee, Y. K., & Kim, J. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.020 · Cited by 346
Prions, prionoids and protein misfolding disorders
Scheckel, C., & Aguzzi, A. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0011-4 · Cited by 321
Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons
Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L. W., Huang, C.-L., Errigo, A., Yin, Y., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.004 · Cited by 318
When Does Parkinson Disease Start?
Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.135 · Cited by 312
Genes associated with Alzheimer's disease: an overview and current status
Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311
A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome
Shi, Y., Kirwan, P., Smith, J., MacLean, G., Orkin, S. H., & Livesey, F. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003771 · Cited by 310
Douvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O’Bara, M. A., Sadiq, S., Sim, F. J., Goldman, J., & Fossati, V. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.012 · Cited by 302
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells
Burkhardt, M. F., Martinez, F. J., Wright, S., Ramos, C., Volfson, D., Mason, M., Garnes, J., Dang, V., Lievers, J., Shoukat-Mumtaz, U., et al. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.07.007 · Cited by 300
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.136 · Cited by 287
Lessons from a failed γ-secretase Alzheimer trial
De Strooper, B. (2014) · Cell · doi:10.1016/j.cell.2014.10.016 · Cited by 277
Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease
Shin, Y., Choi, S. H., Kim, E., Bylykbashi, E., Kim, J. A., Chung, S., Kim, D. Y., Kamm, R. D., & Tanzi, R. E. (2019) · Advanced Science · doi:10.1002/advs.201900962 · Cited by 274
Wörsdörfer, P., Dalda, N., Kern, A., Krüger, S., Wagner, N., Kwok, C. K., Henke, E., & Ergün, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52204-7 · Cited by 272
Lotharius, J., Falsig, J., van Beek, J., Payne, S., Dringen, R., Brundin, P., & Leist, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1746-05.2005 · Cited by 262
Ehrlich, M., Mozafari, S., Glatza, M., Starost, L., Velychko, S., Hallmann, A.-L., Cui, Q.-L., Schambach, A., Kim, K.-P., Bachelin, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614412114 · Cited by 257
Differentiation of human oligodendrocytes from pluripotent stem cells
Hu, B.-Y., Du, Z.-W., & Zhang, S.-C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.186 · Cited by 255
Alzheimer's disease, a multifactorial disorder seeking multitherapies
Iqbal, K., & Grundke‐Iqbal, I. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.04.006 · Cited by 255
Mertens, J., Reid, D., Lau, S., Kim, Y., & Gage, F. H. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031534 · Cited by 255
Korecka, J. A., van Kesteren, R. E., Blaas, E., Spitzer, S. O., Kamstra, J. H., Smit, A. B., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063862 · Cited by 253
Lázaro, D. F., Rodrigues, E. F., Langohr, R., Shahpasandzadeh, H., Ribeiro, T., Guerreiro, P., Gerhardt, E., Kröhnert, K., Klucken, J., Pereira, M. D., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004741 · Cited by 252
Lopes Pinheiro, M. A., Kooij, G., Mizee, M. R., Kamermans, A., Enzmann, G., Lyck, R., Schwaninger, M., Engelhardt, B., & de Vries, H. E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.018 · Cited by 247
Systemic inflammatory cells fight off neurodegenerative disease
Schwartz, M., & Shechter, R. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.71 · Cited by 240
Desai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100087 · Cited by 232
Life in 3D is never flat: 3D models to optimise drug delivery
Fitzgerald, K. A., Malhotra, M., Curtin, C. M., O' Brien, F. J., & O' Driscoll, C. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.020 · Cited by 228
Why do so many clinical trials of therapies for Alzheimer's disease fail?
Anderson, R. M., Hadjichrysanthou, C., Evans, S., & Wong, M. M. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32399-1 · Cited by 228
Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination
Hubler, Z., Allimuthu, D., Bederman, I., Elitt, M. S., Madhavan, M., Allan, K. C., Shick, H. E., Garrison, E., T. Karl, M., Factor, D. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0360-3 · Cited by 226
Juopperi, T. A., Kim, W. R., Chiang, C.-H., Yu, H., Margolis, R. L., Ross, C. A., Ming, G.-L., & Song, H. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-17 · Cited by 225
Barateiro, A., & Fernandes, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.04.018 · Cited by 207
Virlogeux, A., Moutaux, E., Christaller, W., Genoux, A., Bruyère, J., Fino, E., Charlot, B., Cazorla, M., & Saudou, F. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.013 · Cited by 200
Lee, H.-K., Velazquez Sanchez, C., Chen, M., Morin, P. J., Wells, J. M., Hanlon, E. B., & Xia, W. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163072 · Cited by 190
Lysolecithin induces demyelination in vitro in a cerebellar slice culture system
Birgbauer, E., Rao, T. S., & Webb, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20248 · Cited by 188
T-Cells in Alzheimer's Disease
Town, T., Tan, J., Flavell, R. A., & Mullan, M. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:3:255 · Cited by 183
Why have we failed to achieve neuroprotection in Parkinson's disease?
Olanow, C. W., Kieburtz, K., & Schapira, A. H. V. (2009) · Annals of Neurology · doi:10.1002/ana.21461 · Cited by 183
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model
Baik, S. H., Cha, M.-Y., Hyun, Y.-M., Cho, H., Hamza, B., Kim, D. K., Han, S.-H., Choi, H., Kim, K. H., Moon, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.003 · Cited by 181
Crain, S. M. (1966) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60135-x · Cited by 181
APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons.
Moore, S., Evans, L. D. B., Andersson, T., Portelius, E., Smith, J., Dias, T. B., Saurat, N., McGlade, A., Kirwan, P., Blennow, K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.068 · Cited by 179
Camnasio, S., Carri, A. D., Lombardo, A., Grad, I., Mariotti, C., Castucci, A., Rozell, B., Riso, P. L., Castiglioni, V., Zuccato, C., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.042 · Cited by 173
Modeling Neurological Diseases With Human Brain Organoids
Wang, H. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00015 · Cited by 173
Geschwind, M. D. (2015) · Continuum · doi:10.1212/con.0000000000000251 · Cited by 171
EAE: imperfect but useful models of multiple sclerosis
’t Hart, B. A., Gran, B., & Weissert, R. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.006 · Cited by 169
Che, Y., Hou, L., Sun, F., Zhang, C., Liu, X., Piao, F., Zhang, D., Li, H., & Wang, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0468-2 · Cited by 168
Song, L., Yuan, X., Jones, Z., Griffin, K., Zhou, Y., Ma, T., & Li, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-42439-9 · Cited by 168
Nekrasov, E. D., Vigont, V. A., Klyushnikov, S. A., Lebedeva, O. S., Vassina, E. M., Bogomazova, A. N., Chestkov, I. V., Semashko, T. A., Владимировна, К. Е., Suldina, L. A., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0092-5 · Cited by 163
Sproul, A. A., Jacob, S., Pre, D., Kim, S. H., Nestor, M. W., Navarro-Sobrino, M., Santa-Maria, I., Zimmer, M., Aubry, S., Steele, J. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084547 · Cited by 162
Neurons and Astrocytes Respond to Prion Infection by Inducing Microglia Recruitment
Marella, M., & Chabry, J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4303-03.2004 · Cited by 156
Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
Seo, J., Kritskiy, O., Watson, L. A., Barker, S. J., Dey, D., Raja, W. K., Lin, Y.-T., Ko, T., Cho, S., Penney, J., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0621-17.2017 · Cited by 156
Bolognin, S., Fossépré, M., Qing, X., Jarazo, J., Ščančar, J., Moreno, E. L., Nickels, S., Wasner, K., Ouzren-Zarhloul, N., Walter, J., et al. (2018) · Advanced Science · doi:10.1002/advs.201800927 · Cited by 151
Collins, S. J., McLean, C., & Masters, C. L. (2001) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.0919 · Cited by 148
Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2
Lee, S., Park, C., Han, J. W., Kim, J. Y., Cho, K.-W., Kim, S., Kim, S., Lee, S.-J., Oh, S. Y., Tanaka, Y., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309833 · Cited by 148
Moreno, E. L., Hachi, S., Hemmer, K., Trietsch, S. J., Baumuratov, A., Hankemeier, T., Vulto, P., Schwamborn, J. C., & Fleming, R. M. T. (2015) · Lab on a Chip · doi:10.1039/c5lc00180c · Cited by 145
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 145
Central nervous system remyelination in culture — A tool for multiple sclerosis research
Zhang, H., Jarjour, A. A., Boyd, A. L., & Williams, A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.04.009 · Cited by 143
Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations
Zhang, Z., Almeida, S., Lu, Y., Nishimura, A. L., Peng, L., Sun, D., Wu, B., Karydas, A. M., Tartaglia, M. C., Fong, J. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076055 · Cited by 142
Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M. D., Tartaglia, M. C., Gao, F., Gianni, D., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.007 · Cited by 140
Preparation of organotypic hippocampal slice cultures for long-term live imaging
Gogolla, N., Galimberti, I., Paola, V. D., & Caroni, P. (2006) · Nature Protocols · doi:10.1038/nprot.2006.168 · Cited by 136
Buntinx, M., Vanderlocht, J., Hellings, N., Vandenabeele, F., Lambrichts, I., Raus, J., Ameloot, M. M., Stinissen, P., & Steels, P. (2003) · Journal of Neurocytology · doi:10.1023/a:1027324230923 · Cited by 135
3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”
Choi, S. H., Kim, Y. H., Quinti, L., Tanzi, R. E., & Kim, D. Y. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0139-7 · Cited by 132
Cell cycle inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy
Hor, J. H., Soh, E. S.-Y., Tan, L. Y., Lim, V. J. W., Santosa, M. M., Winanto, W., Ho, B. X., Fan, Y., Soh, B.-S., & Ng, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1081-0 · Cited by 118
Human Neurospheroid Arrays for In Vitro Studies of Alzheimer’s Disease
Jorfi, M., D’Avanzo, C., Tanzi, R. E., Kim, D. Y., & Irimia, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-20436-8 · Cited by 116
Smirnova, L., Harris, G., Delp, J., Valadares, M. C., Pamies, D., Högberg, H. T., Waldmann, T., Leist, M., & Härtung, T. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1637-z · Cited by 115
Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids
Groveman, B. R., Foliaki, S. T., Orru, C. D., Zanusso, G., Carroll, J. A., Race, B., & Haigh, C. L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0742-2 · Cited by 113
Mehta, S. R., Tom, C. M., Wang, Y., Bresee, C., Rushton, D., Mathkar, P. P., Tang, J., & Mattis, V. B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.076 · Cited by 112
Jang, J., Yoo, J.-E., Lee, J., Lee, D. R., Kim, J. Y., Huh, Y. J., Kim, D., Park, C., Hwang, D., Kim, H.-S., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.3.015 · Cited by 112
Alzheimer's in 3D culture: Challenges and perspectives
D'Avanzo, C., Aronson, J., Kim, Y. H., Choi, S. H., Tanzi, R. E., & Kim, D. Y. (2015) · BioEssays · doi:10.1002/bies.201500063 · Cited by 111
Automated microfluidic cell culture of stem cell derived dopaminergic neurons
Kane, K. I. W., Moreno, E. L., Hachi, S., Walter, M., Jarazo, J., Oliveira, M. A. P., Hankemeier, T., Vulto, P., Schwamborn, J. C., Thoma, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-34828-3 · Cited by 111
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings
Henley, D. B., Sundell, K. L., Sethuraman, G., Dowsett, S. A., & May, P. C. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.939167 · Cited by 103
Silva, M. C., Cheng, C., Mair, W., Almeida, S., Fong, H., Biswas, M. H. U., Zhang, Z., Huang, Y., Temple, S., Coppola, G., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.001 · Cited by 103
Pietronigro, E. C., Zenaro, E., Bianca, V. D., Dusi, S., Terrabuio, E., Iannoto, G., Slanzi, A., Ghasemi, S., Nagarajan, R., Piacentino, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48538-x · Cited by 102
Self-citationSpeicher, A. M., Wiendl, H., Meuth, S. G., & Pawlowski, M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0347-z · Cited by 100
Song, B., Sun, G., Herszfeld, D., Sylvain, A., Campanale, N., Hirst, C. E., Caine, S., Parkington, H. C., Tonta, M. A., Coleman, H. A., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.12.001 · Cited by 98
Krencik, R., Seo, K., van Asperen, J. V., Basu, N., Cvetkovic, C., Barlas, S., Chen, R. Y., Ludwig, C., Wang, C., Ward, M. E., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.026 · Cited by 96
Ehrlich, M., Hallmann, A.-L., Reinhardt, P., Araúzo-Bravo, M. J., Korr, S., Röpke, A., Psathaki, O. E., Ehling, P., Meuth, S. G., Oblak, A. L., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.06.001 · Cited by 94
van Vliet, E., Morath, S., Eskes, C., Linge, J. P., Rappsilber, J., Honegger, P., Härtung, T., & Coecke, S. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.007 · Cited by 93
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells
Zhang, X.-M., Yin, M., & Zhang, M. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.36 · Cited by 93
Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner
Krejciova, Z., Alibhai, J. D., Zhao, C. N., Krencik, R., Rzechorzek, N. M., Ullian, E. M., Manson, J. C., Ironside, J. W., Head, M. W., & Chandran, S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161547 · Cited by 93
Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons
Wang, S., Wang, B., Pan, N., Fu, L., Wang, C., Song, G., An, J., Liu, Z., Zhu, W., Guan, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep09232 · Cited by 92
Ohmine, S., Squillace, K. A., Hartjes, K. A., Deeds, M. C., Armstrong, A. S., Thatava, T., Sakuma, T., Terzic, A., Kudva, Y. C., & Ikeda, Y. (2012) · Aging · doi:10.18632/aging.100428 · Cited by 90
The prion organotypic slice culture assay—POSCA
Falsig, J., & Aguzzi, A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.13 · Cited by 87
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
Zhang, Y., Schmid, B., Nikolaisen, N. K., Rasmussen, M. A., Aldana, B. I., Agger, M. P., Calløe, K., Stummann, T. C., Larsen, H. M., Nielsen, T. T., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.012 · Cited by 87
Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson’s Disease
Chlebanowska, P., Tejchman, A., Sułkowski, M., Skrzypek, K., & Majka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030694 · Cited by 86
Fuller, H. R., Mandefro, B., Shirran, S. L., Gross, A. R., Kaus, A. S., Botting, C. H., Morris, G. E., & Sareen, D. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00506 · Cited by 78
Characterization of three human cell line models for high‐throughput neuronal cytotoxicity screening
Tong, Z., Högberg, H. T., Kuo, D. C., Sakamuru, S., Xia, M., Smirnova, L., Härtung, T., & Gerhold, D. L. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3334 · Cited by 78
Son, M., Sim, H., Son, Y., Jung, K. B., Lee, M. ‐., Oh, J., Chung, S. ‐., Jung, C., & Kim, J. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12396 · Cited by 78
Primary Culture of Mouse Dopaminergic Neurons
Gaven, F., Marin, P., & Claeysen, S. (2014) · Journal of Visualized Experiments · doi:10.3791/51751 · Cited by 77
Leite, C., Silva, N. T., Mendes, S., Ribeiro, A., de Faria, J. P., Lourenço, T., dos Santos, F., Andrade, P. Z., Cardoso, C. M. P., Vieira, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111059 · Cited by 76
Nakamura, M., Shiozawa, S., Tsuboi, D., Amano, M., Watanabe, H., Maeda, S., Kimura, T., Yoshimatsu, S., Kisa, F., Karch, C. M., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.011 · Cited by 76
Prion Diseases and the Immune System
Aucouturier, P., Carp, R. I., Carnaud, C., & Wısnıewskı, T. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4875 · Cited by 74
Limitations of cellular models in Parkinson’s disease research
Falkenburger, B. H., & Schulz, J. B. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_40 · Cited by 71
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
Lázaro, D. F., Pavlou, M. A. S., & Outeiro, T. F. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.05.007 · Cited by 70
N-Cadherin Is Involved in Axon-Oligodendrocyte Contact and Myelination
Schnädelbach, O., Özen, Í., Blaschuk, O. W., Gour, B. J., Meyer, R. L., & Fawcett, J. W. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.0961 · Cited by 63
Buttiglione, M., Vitiello, F., Sardella, E., Petrone, L., Nardulli, M., Favia, P., d’Agostino, R., & Gristina, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.022 · Cited by 62
Recent advances in understanding multiple sclerosis
Stys, P. K., & Tsutsui, S. (2019) · F1000Research · doi:10.12688/f1000research.20906.1 · Cited by 60
Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 In vitro
Xia, G., Santostefano, K. E., Hamazaki, T., Liu, J., Subramony, S. H., Terada, N., & Ashizawa, T. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9930-2 · Cited by 59
LaVail, J. H., & Wolf, M. K. (1973) · American Journal of Anatomy · doi:10.1002/aja.1001370105 · Cited by 58
Sun, X., Song, J., Huang, H., Chen, H., & Qian, K. X. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1048-1 · Cited by 57
Raya, A., Rodríguez-Pizà, I., Arán, B., Consiglio, A., Barri, P. N., Veiga, A., & Belmonte, J. C. I. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.038 · Cited by 51
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
Lázaro, D. F., Dias, M. C., Čarija, A., Navarro, S., Madaleno, C. S., Tenreiro, S., Ventura, S., & Outeiro, T. F. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0402-8 · Cited by 50
Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders
Doussau, F., Dupont, J. L., Néel, D., Schneider, A., Poulain, B., & Bossu, J. L. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1356285 · Cited by 50
Lopes, F. M., Bristot, I. J., da Motta, L. L., Parsons, R. B., & Klamt, F. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8454-x · Cited by 48
Daviaud, N., Garbayo, E., Lautram, N., Franconi, F., Lemaire, L. P., Pérez‐Pinzón, M. A., & Montero‐Menei, C. N. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.021 · Cited by 47
Park, J., Baik, S. H., Mook‐Jung, I., Irimia, D., & Cho, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02231 · Cited by 47
Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells
Shoji, E., Woltjen, K., & Sakurai, H. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_257 · Cited by 45
Gordon, K., Clouaire, T., Bao, X. X., Kemp, S. E., Xenophontos, M., de Las Heras, J. I., & Stancheva, I. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1351 · Cited by 44
ALS lymphoblastoid cell lines as a considerable model to understand disease mechanisms
Pansarasa, O., Bordoni, M., Dufruca, L., Diamanti, L., Sproviero, D., Trotti, R., Bernuzzi, S., Salvia, S. L., Gagliardi, S., Ceroni, M., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031625 · Cited by 43
Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model
Taylor-Whiteley, T. R., Maitre, C. L. L., Duce, J. A., Dalton, C., & Smith, D. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038042 · Cited by 43
Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification
Kumar, S., Blangero, J., & Curran, J. E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_2 · Cited by 42
Human central nervous system tissue culture: a historical review and examination of recent advances
Walsh, K. A., Megyesi, J. F., & Hammond, R. R. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.002 · Cited by 41
Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation
Efremova, L. V., Chovancova, P., Adam, M., Gutbier, S., Schildknecht, S., & Leist, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1702-2 · Cited by 41
Zhang, Y., Li, X., Ćirić, B., Ma, C., Gran, B., Rostami, A. M., & Zhang, G. (2016) · Molecular Therapy · doi:10.1016/j.ymthe.2016.12.008 · Cited by 41
iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery
Costamagna, G., Andreoli, L., Corti, S. P., & Faravelli, I. (2019) · Cells · doi:10.3390/cells8111438 · Cited by 41
Marotta, N., Kim, S., & Krainc, D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1703671 · Cited by 41
Weinert, M., Selvakumar, T., Tierney, T. S., & Alavian, K. N. (2015) · Journal of Visualized Experiments · doi:10.3791/52475-v · Cited by 40
Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming
Sacco, A. M., Belviso, I., Romano, V., Carfora, A., Schönauer, F., Nurzyńska, D., Montagnani, S., Meglio, F. D., & Castaldo, C. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14316 · Cited by 40
Harischandra, D. S., Rokad, D., Ghaisas, S., Verma, S., Robertson, A., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165533 · Cited by 39
Matamoros‐Angles, A., Gayosso, M., Richaud‐Patín, Y., di Domenico, A., Vergara, C., Hervera, A., Sousa, A., Fernández‐Borges, N., Consiglio, A., Gavín, R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0506-6 · Cited by 38
Neuronal-glial populations form functional networks in a biocompatible 3D scaffold
Smith, I., Haag, M., Ugbode, C., Tams, D. M., Rattray, M., Przyborski, S. A., Bithell, A., & Whalley, B. J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.044 · Cited by 36
Vigont, V. A., Nekrasov, E. D., Shalygin, A. V., Gusev, K. O., Klushnikov, S., Illarioshkin, S. N., Lagarkova, M. A., Киселев, С. Л., & Kaznacheyeva, E. V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00696 · Cited by 36
An organotypic culture model to study nigro-striatal degeneration
Cavaliere, F., Vicente, E. S., & Matute, C. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.02.008 · Cited by 35
Erratum: Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.184 · Cited by 35
�stergaard, K., Finsen, B. R., & Zimmer, J. (1995) · Experimental Brain Research · doi:10.1007/bf00241966 · Cited by 34
Kearns, S. M., Scheffler, B., Goetz, A. K., Lin, D. D., Baker, H., Roper, S. N., Mandel, R. J., & Steindler, D. A. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.03.020 · Cited by 34
Cited by
Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham, L. K., Liddelow, S. A., Temple, S., Benowitz, L. I., Di Polo, A., Wellington, C., Goldberg, J. L., He, Z., Duan, X., Bu, G., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00524-0 · Cited by 324
Ramos, D. M., Skarnes, W. C., Singleton, A. B., Cookson, M. R., & Ward, M. E. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.022 · Cited by 107
The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Ogunmokun, G., Dewanjee, S., Chakraborty, P., Valupadas, C., Chaudhary, A., Kolli, V., Anand, U., Vallamkondu, J., Goel, P., Paluru, H. P. R., et al. (2021) · Cells · doi:10.3390/cells10102790 · Cited by 85
Kaya, Z. B., Santiago-Padilla, V., Lim, M., Boschen, S. L., Atilla, P., & McLean, P. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-55516-5 · Cited by 58
Arfaei, R., Mikaeili, N., Daj, F., Boroumand, A., Kheyri, A., Yaraghi, P., Shirzad, Z., Keshavarz, M., Hassanshahi, G., Jafarzadeh, A., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112328 · Cited by 27
Metadata
- Authors
- Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-13
- Volume
- 8
- Pages
- 328-328
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3025087901
- Cited by
- 290
- References
- 225
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.